Avantor Investor Day Presentation Deck
Driving growth and margin expansion in new segments
LABORATORY
SOLUTIONS
Focus on high-growth workflows
Increase proprietary content
Retain and win new customer accounts by
focusing on commercial excellence and customer
experience
$4.7B
2023E REPORTED
REVENUE
~15%
2023E ADJ.
OPERATING MARGIN
BIOSCIENCE
PRODUCTION
-
-
-
2023E financials based on midpoint of FY 2023 guidance, as of Q3 2023 earnings call.
Segment financials based on management estimates for FY2023. Effective date for the new segment structure is 1/1/24.
3
OPERATING
PRIORITIES
Maintain leading materials position in high-growth
applications (e.g., mAbs in bioprocessing)
$2.3B
2023E REPORTED
REVENUE
Introduce innovative, custom solutions that are
spec'd in
Higher growth + higher margin → "mix up"
-26%
2023E ADJ.
OPERATING MARGIN
Navantor™ 77View entire presentation